- NCIt
- C4413
Loading cancer entity…
Loading cancer entity…
Clinical trials
13 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05114707 | Camrelizumab Plus Chemoradiotherapy for Patients With Locoregional Cancer of Nasal Cavity and Paranasal Sinuses | unknown | Phase 2 | 57 | Sun Yat-sen UniversityOTHER | 1 | Nov 10, 2021 | clinicaltrials |
Data updated 22 days agoSource updated Nov 10, 2021source: clinicaltrials